Company Filing History:
Years Active: 2023
Title: Sevim Ozgur Bruderle: Innovator in Multispecific Binding Proteins
Introduction
Sevim Ozgur Bruderle is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of multispecific binding proteins. Her innovative work has led to the filing of a patent that showcases her expertise and creativity in this area.
Latest Patents
Sevim holds a patent for "PseudoFab-based multispecific binding proteins." This patent describes binding proteins that comprise a pseudoFab domain, which includes a stabilized knockout domain and a second VH/VL that form a first functional antigen binding domain. The patent also covers multispecific binding proteins that include at least one pseudoFab, as well as nucleic acids encoding these binding proteins, expression vectors, host cells, pharmaceutical compositions, and methods of treatment involving the administration of these proteins.
Career Highlights
Sevim is currently employed at Sanofi, a global healthcare company that focuses on patient needs and innovative solutions. Her role at Sanofi allows her to work on cutting-edge research and development projects that aim to improve health outcomes through advanced biotechnological solutions.
Collaborations
Sevim collaborates with notable colleagues, including Christian Beil and Karl-Christian Engel. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in the field of biotechnology.
Conclusion
Sevim Ozgur Bruderle is a trailblazer in the development of multispecific binding proteins, with a patent that reflects her innovative spirit and dedication to advancing biotechnology. Her work at Sanofi and collaborations with esteemed colleagues further solidify her impact in the industry.